MedPath

INSTITUTE OF LIVER AND BILIARY SCIENCES

INSTITUTE OF LIVER AND BILIARY SCIENCES logo
🇮🇳India
Ownership
-
Employees
-
Market Cap
-
Website

To Assess the Efficacy of Early Introduction of a Combination of Low Dose Vasopressin Analogue in Addition to Noradrenaline as a Vasopressor in Patients of Cirrhosis With Septic Shock

Not Applicable
Completed
Conditions
Cirrhosis With Septic Shock
Interventions
First Posted Date
2015-06-10
Last Posted Date
2017-11-06
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Target Recruit Count
184
Registration Number
NCT02468063
Locations
🇮🇳

Institute of Liver and Biliary Sciences, New Delhi, Delhi, India

To Compare the Efficacy of Carbepenem Versus Carbepenem Plus GM-CSF in Difficult To Treat Spontaneous Bacterial Peritonitis

Not Applicable
Completed
Conditions
Spontaneous Bacterial Peritonitis
Interventions
Drug: Carbepenem
Drug: GMCSF (of Granulocyte-Monocyte Colony-Stimulating Factor) .
First Posted Date
2015-06-10
Last Posted Date
2017-11-06
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Target Recruit Count
146
Registration Number
NCT02468089
Locations
🇮🇳

Institute of Liver and Biliary Sciences, New Delhi, Delhi, India

To Study The Incidence And Outcome Of Paracentesis Induced Circulatory Dysfunction in Decompensated Cirrhotics Undergoing Less Than 5 Litres Of Ascitic Fluid Tap With Or Without Albumin Infusion.

Not Applicable
Completed
Conditions
Decompensated Cirrhosis
Interventions
Drug: ascitic fluid
First Posted Date
2015-06-10
Last Posted Date
2017-06-12
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Target Recruit Count
80
Registration Number
NCT02467322
Locations
🇮🇳

Institute of Liver and Biliary Sciences, New Delhi, Delhi, India

Incidence And Outcome Of Paracentesis Induced Circulatory Dysfunction In Acute-On-Chronic Liver Failure.

Not Applicable
Completed
Conditions
Acute on Chronic Liver Failure
Interventions
Drug: Ascitic fluid
First Posted Date
2015-06-10
Last Posted Date
2017-11-28
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Target Recruit Count
80
Registration Number
NCT02467348
Locations
🇮🇳

Institute of Liver and Biliary Sciences, New Delhi, Delhi, India

To Compare the Efficacy and Safety of Carvedilol With or Without Simvastatin in Patients With Portal Hypertension and Esophageal Varices.

Not Applicable
Completed
Conditions
Cirrhosis With Esophageal Varices
Interventions
First Posted Date
2015-06-08
Last Posted Date
2018-05-11
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Target Recruit Count
220
Registration Number
NCT02465645
Locations
🇮🇳

Institute of Liver and Biliary Sciences, New Delhi, Delhi, India

To Evaluate the Safety and Efficacy of Sofosbuvir and Ribavirin in Patients With HCV (Genotype 3) Related Decompensated Cirrhosis

Not Applicable
Terminated
Conditions
HCV Related Cirrhosis
Interventions
First Posted Date
2015-06-08
Last Posted Date
2017-01-19
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Target Recruit Count
62
Registration Number
NCT02464631
Locations
🇮🇳

Institute of Liver and Biliary Sciences, New Delhi, Delhi, India

Comparison And Outcomes Of Fluid Resucitation With 0.9% Normal Saline And 5% Albumin In Cirrhosis Patients With Sepsis Induced Hypotension

Not Applicable
Completed
Conditions
Cirrhosis With Septic Shock
Interventions
Drug: 5% albumin Infusion
First Posted Date
2015-06-04
Last Posted Date
2015-12-30
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Target Recruit Count
308
Registration Number
NCT02462902
Locations
🇮🇳

Institute of Liver and Biliary Sciences, New Delhi, Delhi, India

Role of Hypertonic Saline Versus Mannitol in the Management of Raised Intracranial Pressure in Patients With ALF

Not Applicable
Completed
Conditions
Acute Liver Failure
Interventions
Drug: 3% hypertonic saline
First Posted Date
2015-06-02
Last Posted Date
2016-02-17
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Target Recruit Count
52
Registration Number
NCT02460510
Locations
🇮🇳

Institute of Liver and Biliary Sciences, New Delhi, Delhi, India

Pentoxyphilline Versus Fecal Microbiota Therapy in Severe Alcoholic Hepatitis

Not Applicable
Completed
Conditions
Alcoholic Hepatitis
Interventions
Drug: Pentoxiphylline
Drug: Stool microbiota transplantation
First Posted Date
2015-05-29
Last Posted Date
2019-08-15
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Target Recruit Count
32
Registration Number
NCT02458079
Locations
🇮🇳

Institute of Liver and Biliary Sciences, New Delhi, Delhi, India

© Copyright 2025. All Rights Reserved by MedPath